2 Drug Stocks Dinged at Goldman

China reportedly halted purchases of soy out of the U.S.

 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

OPENING VIEW     5/30/2019
Turn $1,000 into $1.57 Million - with "Holy Grail of Medicine" On September 10, 2018, a tiny biotech firm won a patent on a new treatment that can "Cut & Paste" any disease from your body. The Nobel Prize Committee called it "The Holy Grail of Medicine." This under-the-radar company is not yet a household name. Our research proves that anyone who gets in now could turn $1,000 into $1.57 Million >>>
Stock Futures Inch Higher After GDP By Emma Duncan Share On U.S. stock futures are inching toward a positive open, with the Dow Jones Industrial Average (DJI) pointed higher, as traders digest the latest gross domestic product (GDP) estimate. The Commerce Department said the U.S. economy grew at a 3.1% pace in the first quarter, exceeding expectations. Bond yields are also on the rise, despite reports that China is halting soy purchases out of the U.S. Futures on the Nasdaq-100 (NDX) and S&P 500 Index (SPX) are also moving higher, though all three indexes remain on pace for a steep monthly loss. Continue reading for more on today's market, including:  2 ETFs with hot options after China's latest trade threat.  The penny stock that just quadrupled.  A pair of drug stocks dinged at Goldman. Plus, analysts pounce on Capri; the stock enjoying a Game of Thrones lift; and Dollar Tree sinks on disappointing quarterly report. >> Continue reading...
LATEST HEADLINES
>> Wall Street Continues Bearish Onslaught of Steel Stocks X and STLD stocks were hit with more bearish attention >> Dow Loses 221 Points Amid Trade, Treasury Anxieties China's next tariff weapon could be rare earth minerals >> 3 Stocks Making Volatile Moves Today Cara Therapeutics stock is higher on its phase 3 results >> Options Traders Blitz 2 Metals ETFs Amid Trade Tensions One fund is pacing toward its worst month in years >> IRA/401K Investment Guide: 2019 Stock Market Crash Use gold to protect any IRA, 401(k), or retirement account from a looming financial crisis. ADVERTISEMENT A Rare Opportunity to Turn $1,000 into $1.57 Million On September 10, 2018, a tiny biotech firm won a patent on a new treatment that can "Cut & Paste" any disease from your body. The Nobel Prize Committee called it "The Holy Grail of Medicine." This under-the-radar company is not yet a household name. Our research proves that anyone who gets in now could turn $1,000 into $1.57 Million >>>
To ensure delivery of Schaeffer's Opening View, add us to your contacts! For more information, please visit this link for further instructions. This email was sent to phanhoa1821960.trader@blogger.com because you are a registered subscriber to Schaeffer's Opening View or have signed up to receive emails from www.schaeffersresearch.com. Don't want to receive Schaeffer's Opening View? You can unsubscribe here. For more information about our privacy practices, please review our Privacy Policy or our Terms & Conditions. Have a question, comment or concern? We’ll respond quickest if you call (800) 448-2080, email, or write to:
		SCHAEFFER'S OPENING VIEW enews@schaeffer.com 5151 Pfeiffer Rd. Suite 250 Cincinnati, OH, 45242 USA 800-448-2080 www.schaeffersresearch.com